Drug
Futibatinib
Futibatinib: highest development phase Phase 3, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Futibatinib NCT05615818 | Phase 3 | Biliary Tract Neoplasms |
Latest
No recent events.
Follow Futibatinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.